Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hyperthermia × Surgical Procedures, Operative × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 29 Rectal Neoplasms 22 Esophageal Neoplasms 19 Breast Neoplasms 19 Stomach Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 12 Lung Neoplasms 12 Pancreatic Neoplasms 11 Glioblastoma 11 Sarcoma 9 Head and Neck Neoplasms 9 Colorectal Neoplasms 9 Brain Neoplasms 9 Neoplasms 8 Colonic Neoplasms 8 Melanoma 6 Glioma 6 Esophageal Squamous Cell Carcinoma 6 Adenocarcinoma Of Esophagus 6 Ovarian Neoplasms 5 Oropharyngeal Neoplasms 5 Hypopharyngeal Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Mouth Neoplasms 4 Gliosarcoma 4 Central Nervous System Neoplasms 4 Astrocytoma 4 Adenocarcinoma of Lung 4 Urinary Bladder Neoplasms 3 Skin Neoplasms 3

Interventions

Diathermy 4 Radiotherapy 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Cisplatin 2 tislelizumab 1 sodium thiosulfate 1 anlotinib 1 Surgical Procedures, Operative 1 Radiation 1 Laparotomy 1 Ifosfamide 1 Fluorouracil 1 Drug Therapy 1 Doxorubicin 1 Docetaxel 1 Dacarbazine 1 Cytoreduction Surgical Procedures 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡